SAN DIEGO – ResMed Inc. (pictured right at Medtrade 2023) recently reported a 29% revenue increase for the third quarter ended March 31, 2023. According to a company press release, revenue increased to $1,116.9 million; up 31% on a constant currency basis. Income from operations increased 28%.
“During the third quarter, we significantly ramped up production and delivery of our cloud-connected flow generator devices to meet ongoing high demand from customers, resulting in strong device sales growth across our global markets,” said Mick Farrell, ResMed’s CEO. “We now have full global availability of our connected AirSense 10 platform, while we continue to ramp production and availability across more geographies of our AirSense 11 platform.
“The bottom line is this: We can now support global customer demand for CPAP and APAP devices to serve the entire sleep device market,” Farrel continued via press release. “This is great news for physicians, providers, and especially for patients. We also saw very strong growth in our mask and patient interfaces businesses globally, demonstrating a sustainable focus on patient adherence and resupply. Our outside-hospital software-as-a-service business achieved high-single-digit growth organically and reached well into double-digit growth with a full quarter of contribution from our MEDIFOX DAN acquisition that we closed last November.”